Biotech

All Articles

Sanofi pays out $110M upfront for late-stage radioligand therapy

.Sanofi has actually created an overdue entrance to the radioligand event, paying for one hundred th...

F 2G increases $100M for 2nd attempt to get new antifungal to market

.After F2G's first try to acquire a new lesson of antifungal to market was derailed due to the FDA, ...

Moderna targets $1.1 B in R&ampD investing slices, falls 5 plans amid productivity pressures

.Moderna has actually vowed to reduce R&ampD costs by $1.1 billion by 2027. The selection to shrink ...

Sanofi's $80M bet on Pivot dystrophy drug ends in period 3 fail

.Simply 4 months after Sanofi wager $80 thousand in beforehand money on Fulcrum Therapeutics' losmap...

Oncternal equity sinks 60% among layoffs, trial discontinuations

.Cancer company Oncternal Therapies is actually folding all its scientific trials and also giving up...

Roche is carrying out chances that its own injectable excessive weight prospect can inevitably illustrate 25% fat burning in late-stage test

.Roche is actually storing out chances that its own injectable being overweight prospect could ultim...

Novo Nordisk hails 'remarkable' fat loss result for dual-acting dental drug in early trial

.Novo Nordisk has actually elevated the top on a stage 1 test of its own dental amylin as well as GL...

AbbVie files a claim against BeiGene over blood cancer cells medicine classified information

.Just a couple of brief full weeks after winning an FDA Fast Track tag for its investigational BTK d...

Lilly provides one-two punch with second tranche of positive records on every week blood insulin applicant

.Quickly after a good data drop for Eli Lilly's efsitora alfa, the Indianapolis-based firm is again ...

BridgeBio cuts genetics treatment budget plan as scientific information disappoint

.BridgeBio Pharma is lowering its gene therapy budget plan as well as drawing back from the method a...